Exploring the Role of Oxidative Stress in the Pathophysiology of Metabolic Syndrome: Implications for Therapeutic Targeting

Metabolic syndrome (MetS) is a cluster of metabolic abnormalities, including central obesity, insulin resistance, hypertension, dyslipidemia, and pro-inflammatory states, which significantly increase the risk of cardiovascular diseases, type 2 diabetes, and other complications. Emerging evidence suggests that oxidative stress plays a critical role in the pathophysiology of MetS by exacerbating inflammation, impairing insulin signaling, and promoting cellular dysfunction. Oxidative stress, defined as an imbalance between the production of reactive oxygen species (ROS) and the body’s antioxidant defenses, contributes to the development and progression of metabolic abnormalities that characterize MetS. This review examines the role of oxidative stress in MetS, focusing on its impact on insulin resistance, endothelial dysfunction, adiposity, and inflammatory responses. Additionally, it explores potential therapeutic approaches aimed at modulating oxidative stress, including the use of antioxidants, lifestyle interventions, and pharmacological agents. Although antioxidant therapies have shown promise, challenges such as the safe and effective use of antioxidants in clinical settings, as well as the complex interactions between oxidative stress and other pathophysiological processes, remain. This article provides a comprehensive overview of the role of oxidative stress in MetS and highlights potential therapeutic strategies to mitigate its effects, offering insights into future research directions in this area. Keywords: Oxidative stress, Metabolic syndrome, Insulin resistance, Inflammation, Therapeutic targeting